The utility of the novel optimized HLH inflammatory (OHI) index for predicting the risk for mortality and causes of death in lymphoma.

Authors

Adi Zoref Lorenz

Adi Zoref Lorenz

Division of immunobiology, Cincinnati Children's Hospital Medical Center and Meir Medical Center, Sackler School of Medicine, Tel Aviv, Israel

Adi Zoref Lorenz , Jun Murakami , Liron Hofstetter , Uri Abadi , Swaminathan Padmanabhan Iyer , Shehab Mohamed , Peter Grant Miller , Abd El Haleem Natour , Shiri Weinstein , Sarah Nikiforow , Benjamin Levine Ebert , Ronit Gurion , Inbar Cohen , Oren Pasvolsky , Pia Raanani , Arnon Nagler , Nancy Berliner , Naval Guastad Daver , Martin Ellis , Michael Jordan

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2022 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia

Track

Hematologic Malignancies

Sub Track

Non-Hodgkin Lymphoma

Citation

J Clin Oncol 40, 2022 (suppl 16; abstr 7570)

DOI

10.1200/JCO.2022.40.16_suppl.7570

Abstract #

7570

Poster Bd #

223

Abstract Disclosures

Similar Posters

First Author: Elia Seguí

First Author: Adi Zoref Lorenz

First Author: Vilma Pacheco-Barcia